Page 55 - ITPS-7-4
P. 55

INNOSC Theranostics and
            Pharmacological Sciences                                                    Biomarkers and drugs in Africa



               and personalized medicine: Current status and further   Austrich-Olivares A, Manzanares J. Biomarkers in
               perspectives with special focus on dermatology.  Exp   psychiatry: Concept, definition, types and relevance to the
               Dermatol. 2016;25(5):333-339.                      clinical reality. Front Psychiatry. 2020;11:432.
               doi: 10.1111/exd.12948                             doi: 10.3389/fpsyt.2020.00432
            25.  Liquid  Biomarkers  in  Melanoma:  Detection  and  37.  Condrat CE, Thompson DC, Barbu MG, et al. miRNAs as
               Discovery  -  Scientific Figure on ResearchGate. Available   biomarkers in disease: Latest findings regarding their role in
               from:    https://www.researchgate.net/figure/advantages-  diagnosis and prognosis. Cells. 2020;9(2):276.
               and-disadvantages-of-current-technologies-in-biomarker-
               discovery_tbl3_322565124 [Last accessed on 25 Jun 2024].     doi: 10.3390/cells9020276
                                                               38.  Gouda HN, Charlson F, Sorsdahl K, et al. Burden of non-
            26.  Kim SH, Weiß C, Hoffmann U, Borggrefe M, Akin I,   communicable diseases in sub-Saharan Africa, 1990-2017:
               Behnes M. Advantages and limitations of current biomarker   Results from the Global Burden of Disease Study 2017.
               research: From experimental research to clinical application.
               Curr Pharm Biotechnol. 2017;18(6):445-455.         Lancet Glob Health. 2019;7(10):e1375-e1387.
                                                                  doi: 10.1016/S2214-109X(19)30374-2
               doi: 10.2174/1389201018666170601091205
                                                               39.  Mathema VB, Na-Bangchang K. A  brief review on
            27.  Mayeux  R.  Biomarkers:  Potential  uses  and limitations.
               NeuroRx. 2004;1(2):182-188.                        biomarkers and proteomic approach for malaria research.
                                                                  Asian Pac J Trop Med. 2015;8(4):253-262.
               doi: 10.1602/neurorx.1.2.182
                                                                  doi: 10.1016/S1995-7645(14)60327-8
            28.  Aronson JK. When I use a word. Too much healthcare-
               Biomarkers. BMJ. 2022;379:o2533.                40.  Walzl G, McNerney R, du Plessis N,  et al. Tuberculosis:
                                                                  Advances and challenges in the development of
               doi: 10.1136/bmj.o2533                             new diagnostics and biomarkers.  Lancet  Infect  Dis.
            29.  Goodsaid F. Challenges of biomarkers in drug discovery and   2018;18(7):e199-e210.
               development. Expert Opin Drug Discov. 2012;7(6):457-461.     doi: 10.1016/S1473-3099(18)30111-7
               doi: 10.1517/17460441.2012.679615               41.  Liu Y, Guan S, Xu H, Zhang N, Huang M, Liu Z.
            30.  Kim B, Kang SY, Kim KM. DNA-protein biomarkers for   Inflammation biomarkers are associated with the incidence
               immunotherapy in the era of precision oncology. J Pathol   of cardiovascular disease: A meta-analysis. Front Cardiovasc
               Transl Med. 2021;55(1):26-32.                      Med. 2023;10:1175174.
               doi: 10.4132/jptm.2020.09.23                       doi: 10.3389/fcvm.2023.1175174
            31.  Ke X, Xiong X, Lin Y, Zhang H. Chimeric RNA and exosomes-  42.  Bravo À, Cases M, Queralt-Rosinach N, Sanz F, Furlong  LI.
               based liquid biopsy. Methods Mol Biol. 2020;2079:211-218.  A  knowledge-driven approach to extract disease-
                                                                  related biomarkers from the literature.  Biomed  Res  Int.
               doi: 10.1007/978-1-4939-9904-0_16                  2014;2014:253128.
            32.  Hosseini  K,  Ranjbar  M,  Pirpour  Tazehkand  A,  et al.      doi: 10.1155/2014/253128
               Evaluation of exosomal non-coding RNAs in cancer using
               high-throughput sequencing. J Transl Med. 2022;20(1):30.  43.  Crutcher M, Waldman S. Biomarkers in the development
                                                                  of individualized treatment regimens for colorectal cancer.
               doi: 10.1186/s12967-022-03231-y                    Front Med. 2022;9:1062423.
            33.  Yu J, Ostowari A, Gonda A, et al. Exosomes as a source of      doi: 10.3389/fmed.2022.1062423
               biomarkers for gastrointestinal cancers.  Cancers  (Basel).
               2023;15(4):1263.                                44.  Hassan S, Hamideh N, Poulos C, Cheema S, Rangwani
                                                                  S, Lio   PA. Atopic dermatitis biomarkers and the
               doi: 10.3390/cancers15041263
                                                                  movement toward personalized treatment.  Dermatitis.
            34.  Aronson JK. Biomarkers and surrogate endpoints. Br J Clin   2021;32(1S):S8-S14.
               Pharmacol. 2005;59(5):491-494.                     doi: 10.1097/DER.0000000000000711
               doi: 10.1111/j.1365-2125.2005.02435.x           45.  Conti V, Corbi G, Costantino M,  et al. Biomarkers to
            35.  Sewpersad S, Pillay TS. Historical perspectives in clinical   personalize the treatment of rheumatoid arthritis: Focus
               pathology: Bence Jones protein-early urine chemistry   on autoantibodies  and pharmacogenetics.  Biomolecules.
               and the impact on modern-day diagnostics. J Clin Pathol.   2020;10(12):1672.
               2021;74(4):212-215.
                                                                  doi: 10.3390/biom10121672
               doi: 10.1136/jclinpath-2020-206675
                                                               46.  Refaat MM, Abdel‐Rehim AS, Elmahdi AR, Mohamed  NA,
            36.  García-Gutiérrez MS, Navarrete F, Sala F, Gasparyan   A,   Ghonaim SS. Diamine oxidase enzyme: A  novel


            Volume 7 Issue 4 (2024)                         11                               doi: 10.36922/itps.3656
   50   51   52   53   54   55   56   57   58   59   60